154 related articles for article (PubMed ID: 29403152)
1. Adrenocortical carcinoma characterized by gynecomastia: A case report.
Takeuchi T; Yoto Y; Ishii A; Tsugawa T; Yamamoto M; Hori T; Kamasaki H; Nogami K; Oda T; Nui A; Kimura S; Yamagishi T; Homma K; Hasegawa T; Fukami M; Watanabe Y; Sasamoto H; Tsutsumi H
Clin Pediatr Endocrinol; 2018; 27(1):9-18. PubMed ID: 29403152
[TBL] [Abstract][Full Text] [Related]
2. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
3. EAA clinical practice guidelines-gynecomastia evaluation and management.
Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-secreting adrenocortical tumor in a postmenopausal woman: a challenging diagnosis.
Mermejo LM; Carvalho FG; Molina CAF; Tucci S; Muglia VF; Elias J; Elias PCL; Castro M; Moreira AC
Endocrinol Diabetes Metab Case Rep; 2021 Mar; 2021():. PubMed ID: 33845455
[TBL] [Abstract][Full Text] [Related]
5. Gynecomastia in a Man With Adrenal Mass.
Saini J; Navin P; Rivera M; Bancos I
JCEM Case Rep; 2024 Jan; 2(1):luad143. PubMed ID: 38192879
[TBL] [Abstract][Full Text] [Related]
6. Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor.
Oddie PD; Albert BB; Hofman PL; Jefferies C; Laughton S; Carter PJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30159150
[TBL] [Abstract][Full Text] [Related]
7. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
[TBL] [Abstract][Full Text] [Related]
8. Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion.
Kuhn JM; Lefebvre H; Duparc C; Pellerin A; Luton JP; Strauch G
J Clin Endocrinol Metab; 2002 May; 87(5):2367-75. PubMed ID: 11994389
[TBL] [Abstract][Full Text] [Related]
9. Feminizing Adrenocortical Carcinoma Without Gynecomastia.
Chentli F; Chabour F; Bouchibane D; Nouar N
Oman Med J; 2017 Jul; 32(4):349-351. PubMed ID: 28804590
[TBL] [Abstract][Full Text] [Related]
10. Virilizing adrenocortical carcinoma advancing to central precocious puberty after surgery.
Kim MS; Yang EJ; Cho DH; Hwang PH; Lee DY
Korean J Fam Med; 2015 May; 36(3):150-3. PubMed ID: 26019766
[TBL] [Abstract][Full Text] [Related]
11. Feminizing adrenocortical adenoma presenting as heterosexual precocious puberty: report of one case.
Hsiao HP; Chao MC; Lin CY; Chen HL; Chiou SS; Chen BH
Acta Paediatr Taiwan; 2005; 46(2):97-100. PubMed ID: 16302588
[TBL] [Abstract][Full Text] [Related]
12. Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.
El Ghorayeb N; Rondeau G; Latour M; Cohade C; Olney H; Lacroix A; Perrotte P; Sabourin A; Mazzuco TL; Bourdeau I
Medicine (Baltimore); 2016 Mar; 95(13):e3180. PubMed ID: 27043680
[TBL] [Abstract][Full Text] [Related]
13. Two Subsequent Metachroneus Solid Tumors: Oncocytic Variant Adrenocortical Carcinoma and Rhabdomyosarcoma of Childhood: Case Report and Literature Review.
Akın O; Ataş E; Atasoy İA; Durmaz N; Kartal Ö
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):225-231. PubMed ID: 32539319
[TBL] [Abstract][Full Text] [Related]
14. Feminizing adrenocortical carcinoma with selective suppression of follicle-stimulating hormone secretion and disorganized steroidogenesis: a case report and literature review.
Saito T; Tojo K; Furuta N; Ono K; Sasano H; Utsunomiya K
Intern Med; 2011; 50(13):1419-24. PubMed ID: 21720063
[TBL] [Abstract][Full Text] [Related]
15. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
[TBL] [Abstract][Full Text] [Related]
16. Pubertal gynecomastia and transient elevation of serum estradiol level.
LaFranchi SH; Parlow AF; Lippe BM; Coyotupa J; Kaplan SA
Am J Dis Child; 1975 Aug; 129(8):927-31. PubMed ID: 1163504
[TBL] [Abstract][Full Text] [Related]
17. Pubertal gynecomastia.
Lazala C; Saenger P
J Pediatr Endocrinol Metab; 2002 May; 15(5):553-60. PubMed ID: 12014513
[TBL] [Abstract][Full Text] [Related]
18. Leptin levels in boys with pubertal gynecomastia.
Dundar B; Dundar N; Erci T; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):929-34. PubMed ID: 16355805
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
[TBL] [Abstract][Full Text] [Related]
20. Partial androgen insensitivity syndrome presenting as pubertal gynecomastia: clinical and hormonal findings and a novel mutation in the androgen receptor gene.
Vaidyanathan P; Kaplowitz P
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30601762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
